Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2025 Earnings Call Transcript February 25, 2026
Sarepta Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-3.58 EPS, expectations were $-0.71.
Operator: Good afternoon, and welcome to Sarepta’s Fourth Quarter 2025 Earnings Results Call. As a reminder, today’s program is being recorded. At this time, I’ll turn the call over to Tam Thornton, Sarepta’s Director of Investor Relations. Please go ahead.
Tamara Thornton: Thank you,...
